Ciclesonide is more effective than budesonide in the treatment of persistent asthma
Authors:
- 31 October 2007
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 20 (5) , 562-570
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- In Vitro metabolism of ciclesonide in human lung and liver precision‐cut tissue slicesBiopharmaceutics & Drug Disposition, 2006
- Identification of enzymes involved in Phase I metabolism of ciclesonide by human liver microsomesEuropean Journal of Drug Metabolism and Pharmacokinetics, 2005
- Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonidePulmonary Pharmacology & Therapeutics, 2005
- Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthmaRespiratory Medicine, 2005
- Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costsPrimary Care Respiratory Journal, 2005
- Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthmaAllergy, 2004
- Once-daily inhaled corticosteroids for the treatment of asthmaCurrent Opinion in Pulmonary Medicine, 2004
- Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or eveningEuropean Respiratory Journal, 2001
- CiclesonideDrugs of the Future, 2001
- The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of AsthmaChest, 1999